Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Central nervous system stimulants
1.2.3 Sodium Oxybate
1.2.4 Selective Serotonin Reuptake Inhibitor (SSRI)
1.2.5 Tricyclic Antidepressants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Narcolepsy With Cataplexy
1.3.3 Narcolepsy Without Cataplexy
1.3.4 Secondary Narcolepsy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Therapeutics Market Perspective (2017-2028)
2.2 Narcolepsy Therapeutics Growth Trends by Region
2.2.1 Narcolepsy Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Narcolepsy Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Narcolepsy Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Narcolepsy Therapeutics Market Dynamics
2.3.1 Narcolepsy Therapeutics Industry Trends
2.3.2 Narcolepsy Therapeutics Market Drivers
2.3.3 Narcolepsy Therapeutics Market Challenges
2.3.4 Narcolepsy Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Therapeutics Players by Revenue
3.1.1 Global Top Narcolepsy Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Narcolepsy Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Narcolepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Narcolepsy Therapeutics Revenue
3.4 Global Narcolepsy Therapeutics Market Concentration Ratio
3.4.1 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Therapeutics Revenue in 2021
3.5 Narcolepsy Therapeutics Key Players Head office and Area Served
3.6 Key Players Narcolepsy Therapeutics Product Solution and Service
3.7 Date of Enter into Narcolepsy Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcolepsy Therapeutics Breakdown Data by Type
4.1 Global Narcolepsy Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Narcolepsy Therapeutics Forecasted Market Size by Type (2023-2028)
5 Narcolepsy Therapeutics Breakdown Data by Application
5.1 Global Narcolepsy Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Narcolepsy Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Narcolepsy Therapeutics Market Size (2017-2028)
6.2 North America Narcolepsy Therapeutics Market Size by Type
6.2.1 North America Narcolepsy Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Narcolepsy Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Narcolepsy Therapeutics Market Share by Type (2017-2028)
6.3 North America Narcolepsy Therapeutics Market Size by Application
6.3.1 North America Narcolepsy Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Narcolepsy Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Narcolepsy Therapeutics Market Share by Application (2017-2028)
6.4 North America Narcolepsy Therapeutics Market Size by Country
6.4.1 North America Narcolepsy Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Narcolepsy Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Narcolepsy Therapeutics Market Size (2017-2028)
7.2 Europe Narcolepsy Therapeutics Market Size by Type
7.2.1 Europe Narcolepsy Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Narcolepsy Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Narcolepsy Therapeutics Market Share by Type (2017-2028)
7.3 Europe Narcolepsy Therapeutics Market Size by Application
7.3.1 Europe Narcolepsy Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Narcolepsy Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Narcolepsy Therapeutics Market Share by Application (2017-2028)
7.4 Europe Narcolepsy Therapeutics Market Size by Country
7.4.1 Europe Narcolepsy Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Narcolepsy Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Type
8.2.1 Asia-Pacific Narcolepsy Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Narcolepsy Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Narcolepsy Therapeutics Market Size by Application
8.3.1 Asia-Pacific Narcolepsy Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Narcolepsy Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Narcolepsy Therapeutics Market Size by Region
8.4.1 Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Narcolepsy Therapeutics Market Size (2017-2028)
9.2 Latin America Narcolepsy Therapeutics Market Size by Type
9.2.1 Latin America Narcolepsy Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Narcolepsy Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Narcolepsy Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Narcolepsy Therapeutics Market Size by Application
9.3.1 Latin America Narcolepsy Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Narcolepsy Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Narcolepsy Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Narcolepsy Therapeutics Market Size by Country
9.4.1 Latin America Narcolepsy Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Narcolepsy Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Type
10.2.1 Middle East & Africa Narcolepsy Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Narcolepsy Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Narcolepsy Therapeutics Market Size by Application
10.3.1 Middle East & Africa Narcolepsy Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Narcolepsy Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Narcolepsy Therapeutics Market Size by Country
10.4.1 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Addrenex Pharmaceuticals, Inc.
11.1.1 Addrenex Pharmaceuticals, Inc. Company Details
11.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
11.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
11.1.5 Addrenex Pharmaceuticals, Inc. Recent Developments
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Company Details
11.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Introduction
11.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2017-2022)
11.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.3 Jazz Pharmaceuticals PLC
11.3.1 Jazz Pharmaceuticals PLC Company Details
11.3.2 Jazz Pharmaceuticals PLC Business Overview
11.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Introduction
11.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2017-2022)
11.3.5 Jazz Pharmaceuticals PLC Recent Developments
11.4 Graymark Healthcare, Inc.
11.4.1 Graymark Healthcare, Inc. Company Details
11.4.2 Graymark Healthcare, Inc. Business Overview
11.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Introduction
11.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
11.4.5 Graymark Healthcare, Inc. Recent Developments
11.5 Arena Pharmaceuticals, Inc.
11.5.1 Arena Pharmaceuticals, Inc. Company Details
11.5.2 Arena Pharmaceuticals, Inc. Business Overview
11.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
11.5.5 Arena Pharmaceuticals, Inc. Recent Developments
11.6 BIOPROJET
11.6.1 BIOPROJET Company Details
11.6.2 BIOPROJET Business Overview
11.6.3 BIOPROJET Narcolepsy Therapeutics Introduction
11.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2017-2022)
11.6.5 BIOPROJET Recent Developments
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Narcolepsy Therapeutics Introduction
11.7.4 Takeda Revenue in Narcolepsy Therapeutics Business (2017-2022)
11.7.5 Takeda Recent Developments
11.8 Ligand Pharmaceuticals, Inc.
11.8.1 Ligand Pharmaceuticals, Inc. Company Details
11.8.2 Ligand Pharmaceuticals, Inc. Business Overview
11.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
11.8.5 Ligand Pharmaceuticals, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer